drugset / Trial / NCT00942604

A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations

NCT00942604

Phase 3 Completed 203 enrolled Peplin
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether topical application of PEP005 is effective for the treatment of actinic keratoses.

Timeline

Start
2009-07
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator ingenol mebutate Small molecule 0.05 % Topical

Indications